Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2025-12-25 @ 1:38 AM
NCT ID:
NCT00001894
Eligibility Criteria:
Patients of either gender, aged 18-80 years.
NYHA functional class III/IV, or syncope, or greater than or equal to 2 presyncope despite verapamil and/or Beta-blocker therapy.
LV outflow tract gradient greater than or equal to 30 mm Hg at rest or greater than or equal to 50 mm Hg following isoproterenol infusion to a heart rate of greater than 100 bpm.
No patients with mid-cavity obstructive HCM.
No patients with LV septal wall thickness less than 15 mm estimated by echocardiography.
No patients with greater than 50 percent luminal narrowing in a major coronary artery vessel.
No patients with chronic atrial fibrillation.
No patients with a positive pregnancy test.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00001894
Study Brief:
Protocol Section:
NCT00001894